| |
| FOLLOWING ECIL 7 |
|
| |
|
| Coming soon... |
|
| |
|
| FOLLOWING ECIL 6 |
|
| |
|
ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients
Simone Cesaro, Tina Dalianis, Christine Hanssen Rinaldo, Minna Koskenvuo, Anna Pegoraro, Hermann Einsele, Catherine Cordonnier and Hans H. Hirsch
J Antimicrob Chemother 2017, doi:10.1093/jac/dkx324 |
|
| |
|
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell
transplant patients.
Frederic Tissot, Samir Agrawal, Livio Pagano, Georgios Petrikkos, Andreas H. Groll, Anna Skiada, Cornelia Lass-Flörl, Thierry Calandra, Claudio Viscoli, Raoul Herbrecht. Haematologica 2017 : 102(3):433-444 |
|
| |
|
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. J Styczynski, W van der Velden, C P. Fox, D Engelhard, R de la Camara, C Cordonnier, P Ljungman on behalf of the Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation (EBMT-IDWP), the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) Haematologica 2016 101(7):803-811
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non–HIV infected patients G Maschmeyer, J Helweg-Larsen, L Pagano, C Robin, C Cordonnier, P Schellongowski Journal of Antimicrobial Chemotherapy 2016, doi:10.1093/jac/dkw155. |
|
| |
|
| FOLLOWING ECIL 5 |
|
| |
|
Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. C Cordonnier, S Cesaro, G Maschmeyer, H Einsele, J P Donnelly, A Alanio, P M. Hauser, K Lagrou, W J G Melchers, J Helweg-Larsen, O Matos, S Bretagne and J Maertens. Journal of Antimicrobial Chemotherapy 2016, doi:10.1093/jac/dkw155.
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with hematological malignancies and stem cell transplant recipients J Maertens, S Cesaro, G Maschmeyer, H Einsele, J P Donnelly, A Alanio, P M. Hauser, K Lagrou, W J G Melchers, J Helweg-Larsen, O Matos, S Bretagne and C Cordonnier Journal of Antimicrobial Chemotherapy 2016, doi:10.1093/jac/dkw157
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with hematological malignancies and stem cell transplant recipients A Alanio, P M. Hauser, K Lagrou, W J G Melchers, J Helweg-Larsen, O Matos, S Cesaro, G Maschmeyer, H Einsele, J P Donnelly, C Cordonnier, J Maertens, S Bretagne Journal of Antimicrobial Chemotherapy 2016, doi:10.1093/jac/dkw156 |
|
| |
|
Response to “Comment on Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients ”by S. Antinori and colleagues.
C CORDONNIER, A ALANIO, S CESARO, G MASCHMEYER, H EINSELE, J. P DONNELLY, P M. HAUSER, K LAGROU, W J. G. MELCHERS, J HELWEG-LARSEN, O MATOS, S BRETAGNE, J MAERTENS on behalf of the 5th European Conference on Infections in Leukemia.
J. Antimicrob. Chemother. 2017 Jan 25. pii: dkw580. doi: 10.1093/jac/dkw580. [Epub ahead of print] |
|
| |
|
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haematopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukemia.
V MALLET, F VAN BÖMMEL, C DOERIG, S PISCHKE, O HERMINE, A LOCASCIULLI, C CORDONNIER, T BERG, D MORADPOUR, H WEDEMEYER, P LJUNGMAN, on behalf of ECIL 5, a joint venture of EBMT, EORTC, ICHS and ELN.
Lancet Infectious Diseases 2016, 16 : 606-17 |
|
| |
|
| FOLLOWING ECIL 4 |
|
| |
|
European Conference on Infections in Leukemia. European
guidelines for diagnosis and treatment of adenovirus infection
in leukemia and stem cell transplantation: summary of
ECIL-4 (2011).
S. Matthes-Martin, T. Feuchtinger, P.J. Shaw, D. Engelhard,
H.H. Hirsch, C. Cordonnier, P. Ljungman, on behalf of
the fourth European Conference on Infections in Leukemia
(ECIL).
Transpl Infect Dis 2012: 14: 555–563. |
|
| |
|
Fourth European Conference on Infections in Leukaemia
(ECIL-4): Guidelines for Diagnosis and Treatment of Human
Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus,
Rhinovirus, and Coronavirus.
Hans H. Hirsch, Rodrigo Martino, Katherine N. Ward, Michael
Boeckh, Hermann Einsele, and Per Ljungman
Clinical
Infectious Diseases Advance Access published November
1, 2012. |
|
| |
|
European guidelines for prevention and management of
influenza in hematopoietic stem cell transplantation and
leukaemia patients: summary of ECIL-4 (2011).
D. Engelhard, B. Mohty, R. de la Camara, C. Cordonnier,
P. Ljungman., on behalf of ECIL, a joint venture of EBMT,
EORTC, ICHS and ELN.
Transpl Infect Dis 2013:
0: 1–14 |
|
| |
|
The role of antibiotic stewardship
in limiting antibacterial resistance among hematology
patients.
Gyssens IC, Kern WV, Livermore D, on behalf of ECIL-4,
a joint venture of EBMT, EORTC, ICHS and ESGICH of ESCMID,
Haematologica 2013, 98 (12), 1821-5 |
|
| |
|
European guidelines for empirical
antibacterial therapy for febrile neutropenic patients
in the era of growing resistance: summary of the 2011
4th European Conference on Infections in Leukemia.
D Averbuch, C Orasch, C Cordonnier, D M. Livermore,
M Mikulska, C Viscoli, I C. Gyssens, W Kern, G Klyasova,
O Marchetti, D Engelhard, M Akova, on behalf of ECIL4,
a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID
and ELN.
Haematologica 2013: 98 (12): 1826-35 |
|
| |
|
Targeted therapy against multi-resistant
bacteria in leukemic and hematopoietic stem cell transplant
recipients - guidelines of the 4th European Conference
on Infections in Leukemia.
D Averbuch, C Cordonnier, D M. Livermore, M Mikulska,
C Orasch, C Viscoli, I C. Gyssens, W Kern, G Klyasova,
O Marchetti, D Engelhard, M Akova, on behalf of ECIL4,
a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID
and ELN.
Haematologica 2013: 98 (12): 1836-47 |
|
| |
|
Aetiology and resistance in bacteraemias
among adult and paediatric haematology and cancer patients.
Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch
D, Cordonnier C, Akova M, for the Fourth European Conference
on Infections in Leukemia Group (ECIL-4), a joint venture
of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID.
J Infect. 2013 Dec 24. [Epub ahead of print] |
|
| |
|
Fourth European Conference on Infections in Leukaemia(ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.
Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, Roilides E, Jan Styczynski, Adilia Warris, and Lehrnbecher T.
Lancet Oncol 2014; 15: e327–40.
The Lancet Oncology |
|
| |
|
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.
Orasch C, Averbuch D, Mikulska M, Cordonnier C, Livermore DM, Gyssens IC, Klyasova G, Engelhard D, Kern W, Viscoli C, Akova M, Marchetti O; for the 4th European Conference on Infections in Leukemia.
Clin Microbiol Infect 2015; 21: e25–e27 |
|
| |
|
| FOLLOWING ECIL 3 |
|
| |
|
European guidelines for antifungal management in leukemia
and hematopoietic stem cell transplant recipients: Summary
of the ECIL3 – 2009 Update
J Maertens, O Marchetti, R Herbrecht, O A. Cornely, U
Flückiger, P Frêre, B Gachot, W J. Heinz, C
Lass-Flörl, P Ribaud, A Thiebaut, C Cordonnier
Bone Marrow Transplant, 2011 May;46(5):709-18. |
|
| |
|
The use of mannan antigen and anti-mannan antibodies
in the diagnosis of invasive candidiasis:
recommendations from the 3rd European Conference on Infections
in Leukemia (ECIL-3).
Authors:
M. Mikulska, T. Calandra, M. Sanguinetti, D. Poulain and
C. Viscoli, on behalf of the third European Conference
on Infections in Leukemia
Critical Care
2010;14(6):R222. Epub 2010 Dec 8. |
|
| |
|
Recommendations for the use of biological markers for
the diagnosis of invasive fungal diseases in leukemic
patients and hematopoietic stem cell transplant recipients
O Marchetti, F Lamoth, M Mikulska, C Viscoli, P Verweij,
S Bretagne, and the European Conference on Infections
in Leukaemia (ECIL) laboratory working groups
Bone
Marrow Transplant, Epub 2011, Sept. 19. |
|
| |
|
Classical diagnostic procedures for the diagnosis of
Invasive Fungal Diseases in patients with Leukemia
M Cavling Arendrup, Chris Kibbler, E Dannaoui, M Ruhnke,
CP Heussel, J Bille
Bone Marrow Transplant,
Epub 2012, Jan. 9. |
|
| |
|
Beta-Glucan antigenemia for the diagnosis of invasive
fungal infections in patients with hematological malignancies:
Systematic review and meta-analysis of cohort studies
F Lamoth, M Cruciani, C Mengoli, E Castagnola, O Lortholary,
M Richardson, O Marchetti, on behalf of the Third European
Conference on Infections in Leukemia (ECIL 3)
Clin
Infect Dis 2012:54,633-43. |
|
| |
|
ECIL-3 classical diagnostic procedures
for the diagnosis of invasive fungal diseases in patients
with leukaemia MC Arendrup, J Bille, E Dannaoui, M Ruhnke,
C-P Heussel, C Kibbler
Bone Marrow Transplant 2012 : 47, 1030–1045 |
|
| |
|
Diagnosis and treatment of mucormycosis in patients
with haematological malignancies: guidelines from the
3rd European Conference on Infections in Leukemia (ECIL
3)
Anna Skiada, Fanny Lanternier, Andreas H. Groll, Livio
Pagano, Stephan Zimmerli, Raoul Herbrecht, Olivier Lortholary,
and George L. Petrikkos
Haematologica 2012 [Epub
ahead of print]
|
|
| |
|
| FOLLOWING ECIL 2 |
|
| |
|
Management of CMV, HHV6, HHV7 and Kaposi-sarcoma herpesvirus
infections in patients with hematological malignancies
including stem cell transplantation.
P Ljungman, R De La Camara, C Cordonnier, H Einsele, D
Engelhard, P Reusser, J Styczynski, K Ward for the European
Conference on Infections in Leukemia.
Bone Marrow
Transplantation, 2008, Aug;42(4):227-40). |
|
| |
|
Management of HSV, VZV, and EBV infections in patients
with hematological malignancies and after SCT : guidelines
from the Second European Conference on Infections in Leukemia.
J Styczynski, P Reusser, H Einsele, R de la Camara, C
Cordonnier, KN Ward, P Ljungman, D Engelhard, for the
European Conference on Infections in Leukemia.
Bone
Marrow Transplant 2009; 43:757-770 |
|
| |
|
| FOLLOWING ECIL 1 |
|
| |
|
The first European Conference on infections in leukaemia:
Why and how?
C. Cordonnier, T Calandra.
Eur J Cancer
2007; Suppl. 5, 2-4. |
|
| |
|
Quinolone prophylaxis for bacterial infections in afebrile
high risk neutropenic patients
G Bucaneve, E Castagnola, C Viscoli, L Leibovici, F Menichetti
Eur J Cancer 2007; Suppl. 5, 5-12. |
|
| |
|
The need for aminoglycosides in combination with betalactams
for high-risk, febrile neutropaenic patients with leukaemia
L Drgona, M Paul, G Bucaneve, T Calandra, F Menichetti
Eur J Cancer 2007; Suppl. 5. 13-22 |
|
| |
|
Empirical use of anti-Gram-positive antibiotics in febrile
neutropaenic cancer patients with acute leukaemia 5
Alain Cometta*, O. Marchetti, T. Calandra
Eur
J Cancer 2007; Suppl. 5. 23-31 |
|
| |
|
Primary antifungal prophylaxis in leukaemia patients.
J Maertens, P Frere, C Lass-Flörl, W Heinz, OA Cornely.
Eur J Cancer 2007;Suppl.5:43-8. |
|
| |
|
Empirical antifungal therapy in neutropenic cancer patients
with persistent fever. Guidelines of the ECIL1 conference.
O Marchetti, C Cordonnier, T Calandra.
Eur J Cancer
2007; Suppl. 5. 32-42. |
|
| |
|
European guidelines for the treatment of invasive candida
and invasive aspergillus infections in adult haematological
patients.
R Herbrecht, U Fluckiger, B Gachot, P Ribaud, A Thiebaut,
C Cordonnier.
Eur J Cancer 2007; Suppl. 5.,
49-59. |
|
|
| |
|
|
